• Understand the recent
scientific advances in the study of glomerular
• Discuss how new technologies might expand the scope of glomerular disease
• Appreciate potential new avenues of therapy for some forms of glomerular
disease, as well as strategies for clinical testing of new reagents.
The target audience is primarily physician-researchers
involved in the treatment of patients with glomerular diseases.